LENZ Therapeutics
Price & Volume
Stats
See moreOpen | $3.65 |
Previous Close | $3.64 |
Day Range | $3.60-$3.70 |
52W Range | $3.35-$42.98 |
Market Cap | $114.5M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $21.4M |
Revenue Growth (YoY) | 9.7% |
Gross Profit (12 Mos) | $19.7M |
Diluted EPS | -$4.13 |
News
See moreYahoo Finance • 2 months ago
Lenz drops as BofA downgrades on a slower VIZZ launch
Yahoo Finance • 3 months ago
William Blair updates conviction list: Oracle in, Meta out and more
Yahoo Finance • 4 months ago
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Yahoo Finance • 5 months ago
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
About
CEO | Mr. Evert B. Schimmelpennink |
Address | 201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 152 |